Rodnan developed a clinical score for assessing skin thickening in patients with systemic sclerosis. The score can be followed over time to monitor effectiveness of interventions. The author is from the University of Pittsburgh School of Medicine.
Sites examined for the 26 sites:
(1) right fingers
(2) left fingers
(3) right hand
(4) left hand
(5) right forearm
(6) left forearm
(7) right arm
(8) left arm
(9) right shoulder
(10) left shoulder
(11) right breast
(12) left breast
(13) right thigh
(14) left thigh
(15) right leg
(16) left leg
(17) right foot
(18) left foot
(19) right toes
(20) left toes
(21) face
(22) neck
(23) anterior chest
(24) abdomen
(25) upper back
(26) lower back
Clinical Involvement |
Points |
no thickening, normal |
0 |
slight but definite thickening |
1 |
mild-to-moderate thickening |
2 |
severe thickening |
3 |
extreme thickening |
4 |
score =
= SUM(points for all 26 sites)
Interpretation:
• minimal score: 0
• maximum score: 104
• The higher the score the more severe the disease.
Limitations:
• The scoring is relatively extensive and may over-represent certain areas of the body. Several modifications of the score have been developed to address some of these issues.
Purpose: To evaluate a patient with systemic sclerosis using the 26 site Rodnan skin score.
Specialty: Immunology/Rheumatology
Objective: laboratory tests, severity, prognosis, stage, response to therapy, disease progression
ICD-10: M34,